CCND3 and metastatic neoplasm: The patient was treated with one cycle of temozolomide, etoposide, and palbociclib (chosen based on CCND3 copy number gain) with concurrent palliative radiation to the same radiation field, but the patient died two weeks later from progressive neurologic decline, 5 months after identification of CNS metastatic disease.